Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ciprofloxacin (ciprofloxacin hydrochloride)
Hankook Korus Pharm Co.
J01MA02
ciprofloxacin (ciprofloxacin hydrochloride)
500mg
tablets film-coated
(20/2x10/) in blister, (100/10x10/) in blister
Prescription
Registered
2020-07-23
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CIPROFLOXACIN-ASTERIA TAB. 500MG (CIPROFLOXACIN) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ciprofloxacin-Asteria Tab. is and what it is used for 2. What you need to know before you take Ciprofloxacin-Asteria Tab. 3. How to take Ciprofloxacin-Asteria Tab. 4. Possible side effects 5. How to store Ciprofloxacin-Asteria Tab. 6. Contents of the pack and other information 1. WHAT CIPROFLOXACIN-ASTERIA TAB. IS AND WHAT IT IS USED FOR Ciprofloxacin-Asteria Tab. contains the active substance ciprofloxacin. Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Adults Ciprofloxacin-Asteria Tab. is used in adults to treat the following bacterial infections: - respiratory tract infections - long lasting or recurring ear or sinus infections - urinary tract infections. Ciprofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the tratement of these infections. - genital tract infections in men and women - gastro-intestinal tract infections and intra-abdominal infections - skin and soft tissue infections - bone and joint infections - to prevent infections due to the bacterium Neisseria meningitidis - anthrax inhalation exposure Ciprofloxacin may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is s Read the complete document
SUMMARY OF PRODUCT CHARACTERISTIC (SPC) OF CIPROFLOXACIN-ASTERIA TAB. 500MG 1. NAME OF THE MEDICINAL PRODUCT Ciprofloxacin-Asteria Tab. 500mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient No. Chemical Name Quantity/ Tab. 1 Ciprofloxacin Hydrochloride 582mg (500mg as ciprofloxacin) Excipients No. Chemical Name Quantity/ Tab. 1 Lactose 56 mg 2 Corn starch 50 mg 3 Hydroxypropyl cellulose 14 mg 4 Sodium starch glycolate 8 mg 5 Magnesium stearate 10 mg 6 Hydroxypropyl- methylcellulose 2910 8 mg 7 Polyethylene Glycol 6000 4 mg 8 Titanium oxide 3 mg 9 Methylene chloride q.s 10 Ethanol q.s 3. PHARMACEUTICAL FORM Film-coated tablets 4. CLINICAL CHARACTERISTICS 4.1 THERAPEUTIC INDICATIONS Ciprofloxacin-Asteria film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Urinary tract infections. Ciprofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the tratement of these infections. • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae - epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae • Infections of the gastro-intestinal tract (e.g. travellers' diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negat Read the complete document